This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Save the date!
November 6–8, 2023Munich, Germany

Keely Zipp
Founder at Stark Strategic Advisors


Keely Zipp is a seasoned life sciences executive with extensive leadership experience in pharma and biotech across a variety of functions, including marketing, corporate development, operations, and corporate strategy. She has a strong track record of leading clinical development strategy, business development, product commercialization, PR/IR, and financing strategy with a focus on Oncology and Rare Disease. Ms. Zipp has over a decade of experience in large pharma and biotech, with positions of increasing responsibility at Wyeth, GSK, and Incyte which included development of business unit- and company-level strategic plans. She has spent the last four years in corporate development leadership positions at private and public biotechs, where her responsibilities included leading business development, clinical development strategy, and financing ($25M Series B2 and leading multiple elements of a $100M IPO on the NASDAQ).

Ms. Zipp has a BA in Biochemistry and Molecular Biology from Dartmouth College (magna cum laude) and a MBA from The Wharton School, University of Pennsylvania.

Agenda Sessions

  • Global dealmaking in a global indication: oncology partnering in 2022